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Background: Anisochilus carnosus (L.f.) wall (Lamiaceae), an annual herb which grows at high altitude is used
extensively in folk medicine for the treatment of ailments such as gastric ulcer and skin diseases. The aim of our
study was to evaluate the anticancer activity of different extracts of the leaves of A.carnosus. An attempt was also
made to estimate the luteolin content in different extracts of Anisochilus carnosus by HPLC (High Performance
Liquid Chromatography).
Methods: In the current study, we explored the cytotoxic potential of petroleum ether, ethanolic and aqueous extracts
of A.carnosus against breast adenocarcinoma cell line (BT-549), by in vitro MTT and SRB assay. We also detected the
luteolin content in different extracts (ethanolic and aqueous) of A.carnosus by using HPLC as a tool of analysis.
Results: The results demonstrate that petroleum ether and ethanolic extract of A.carnosus showed potent cytotoxic
effect against BT-549 with an IC50 of 22.5 μg/ml (petroleum ether extract) and 87.24 μg/ml (ethanolic extract), by SRB
assay, and 18.35 μg/ml (petroleum ether extract) and 58.64 μg/ml (ethanolic extract), by MTT assay. The aqueous extracts
showed less cytotoxic effect with an IC50 of 211.26 μg/ml (by SRB assay) and 238.91 μg/ml (by MTT assay). HPLC results
of luteolin content in various extracts using luteolin as the marker compound indicated the ethanol extract to contain
the highest concentration of luteolin (0.372% w/w). The aqueous extract contained lower concentration of luteolin
(0.282% w/w).
Conclusion: Our findings demonstrate that petroleum ether and ethanolic extract of A.carnosus shows promising
anticancer activity and has the potential to be developed into a therapeutic option for the treatment of cancer.
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Breast cancer continues to be the second most common
cause of cancer associated death among women [1]. It is
projected that 1 in every 8 women will develop breast
cancer in their lifetime [2]. Based on the ACS (American
Cancer Society) report 2014, there are a possibility of
1,665,54 new cases of breast cancer and an estimated
585,720 people will die of this disease [3]. The risk
factors for breast cancer include female sex, menarche at
an early age, menopause at a late age, a family history of
cancer, innate germ-line mutations in tumour-suppressor
genes (e.g., BRCA1, BRCA2, and p53), late age at first
pregnancy or never having given birth, regular alcohol use,
use of menopausal hormone therapy (MHT) and ionising* Correspondence: avemaria_lobo@yahoo.com
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unless otherwise stated.radiation exposure [1,4]. Although, high dose chemo and
radiotherapy have drastically increased the long term
survival of breast cancer patients, they are associated
with severe side effects such as nausea, vomiting, alo-
pecia [5], cancer-related fatigue [6] and cardiovascular
complications [1].
Several findings have indicated that more than two-
third of human cancers could be averted through suit-
able lifestyle modification. According to Richard Doll
and Richard Peto, 35% of death due to cancer is attribut-
able to diet [7]. In this regard, nutritional phytochemi-
cals and plant derived constituents such as flavonoids,
phytosterols, triterpenoids and essential oils hold enor-
mous possibilities for development of a therapy with
considerably fewer side effects for treatment and preven-
tion of cancer [8]. Studies have signified that they can alter
multiple pathways at the same time and inhibit tumourLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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pressor pathways [7,8]. They can block or reverse two
stages of tumour development namely tumour initi-
ation and tumour promotion and thus terminate or im-
pede the development of precancerous cells into
malignant ones [7]. One such class of nutritional phyto-
chemical that have been identified to have incredible
cancer-protective effects is flavonoids. Luteolin is a nat-
urally occurring flavonoid that can be found in a variety
of fruits, vegetables and medicinal herbs [9]. Many epi-
demiological studies suggest a reverse relation between
luteolin consumption and risk of some cancer types.
Anisochilus carnosus (L.f.) wall, a member of the family
Lamiaceae is an annual herb which grows on high alti-
tude among small rocks. In India, it is widely distrib-
uted in Tamil Nadu, Karnataka, Maharashtra and
Rajasthan [10] and is known as Induparni in Sanskrit,
Panjiri-ka patta in Hindi and Kapurli in Marathi [11].
Traditionally, it is widely used by many tribal commu-
nities of Tamil Nadu, Maharashtra and Rajasthan for
the treatment of cough, ulcer, eczema and stomach
ache [12-16]. Phytochemical analysis of this plant
showed it to be rich in active compounds such as flavo-
noids (luteolin, apigenin) [17], phytosterols, triterpenoids,
saponins, tannins [18] and essential oil components (car-
vacrol, α-cis-bergamotene, caryophyllene, β-selinene, cam-
phor) [19].
This paper reports the anticancer activity of different
extracts of A.carnosus against BT-549, an estrogen inde-
pendent breast adenocarcinoma cell line. This study also
aims to determine the luteolin content in different
extracts of the plant and correlate the luteolin content of
extracts to its anticancer activity.
Methods
Plant collection
The leaves of A.carnosus was collected from Udyavar,
Udupi in September 2010 and authenticated by Dr.
Richard Lobo, Pharmacognosist, Manipal College of
Pharmaceutical sciences, Manipal, Karnataka. A vou-
cher specimen with accession number [PP 573] has
been deposited in the Department of Pharmacognosy,
Manipal College of Pharmaceutical Sciences, Manipal,
India.
Reagent and chemicals
The reagents MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide) and SRB (Sulforhoda-
mine B) were purchased from Sigma Aldrich, USA.
Methanol, ethanol (95%), chloroform, petroleum ether,
acetone and benzene were purchased from Ranbaxy
Fine Chemicals Ltd. The reference standard luteolin
was obtained from Sigma Aldrich, USA. All solvents
purchased were of analytical grade.Extraction and fractionation
The dried coarsely powdered leaves of A.carnosus (500 g)
was extracted with solvents petroleum ether (60-80°C) (3x
1 L) and ethanol (3x1 L) using soxhlet extractor. The
solvent- containing extracts were evaporated to dryness
on a rotary evaporator under reduced pressure to obtain
percentage yield of 23.8% w/w and 17% w/w respectively.
Crushed shade-dried leaves (500 g) were kept for cold
maceration in chloroform: water (1:99) for 4 days at room
temperature. The solvent-containing extract was then
filtered and filtrate obtained was concentrated on a water
bath to obtain crude aqueous extract (16.2% w/w).
Human cell line and culture medium
Cell line
Breast tumour carcinoma cell line BT-549 was ob-
tained from NCCS (National Centre for Cell Sciences)
Pune, India. DMEM (Dulbecco’s Modified Eagles Medium)
media and Foetal bovine serum (FBS) was obtained from
Sigma Aldrich, USA.
In vitro MTT assay
The cytotoxicity of A.carnosus against BT-549 cell line
was determined using the Methyl thiazol tetrazolium
(MTT) assay [20]. BT-549 (Breast tumour carcinoma)
cells were harvested from 75 cm2 tissue culture flasks
and inoculated into 96-well flat bottom tissue culture
plate (104 cells/well in 0.1 ml of MEM [Minimum Essen-
tial medium] supplemented with 10% FBS [Foetal Bovine
Serum]) and incubated for 24 hours for attachment. Test
compounds were solubilised just prior to the experiment
in 0.1% DMSO. After incubation for 24 hours, cells were
subjected to several concentrations of the extracts (25,
50, 100 and 200 μg/ml). The cells which received only
the medium containing 0.1% DMSO served as the
control group. Paclitaxel was used as standard. After the
treatment, the media was removed and washed with
200 μl of PBS. To each well of the 96 well plates, 100 μl
of MTT reagent was added and incubated for 4 hours at
37°C. After 4 hours of incubation, the plate was inverted
on a tissue paper to remove MTT reagent. To solubilize
the formazan crystals in the wells, 100 μl of DMSO was
added to each well. The suspension was placed on a
micro-vibrator for 5 minutes and the optical density (O.D)
was measured by a microplate reader at 570 nm. Per-
centage viability of each extract was calculated by using
the formula:




The experiment was performed in three biological
replicates. Results were expressed as Mean ± SEM
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drug concentrations.
In vitro SRB assay
Cell proliferation and viability was determined by a sulfor-
hodamine B (SRB) colorimetric assay [21]. Briefly, BT-549
cells were plated onto 96-well flat bottom tissue culture
plate at a density of 104 cells/well and incubated for
24 hours. Subsequently, cells were treated with various
concentrations of the extract (25, 50, 100, 200 μg /ml).
The cells in the control group received only the
medium containing 0.1% DMSO. Paclitaxel was used as
standard. After 48 hours, the cells were fixed with ice-
cold trichloroacetic acid (100 μl per well, 10% w/v) for
1 hour at 4°C. The plates were washed in distilled water
and allowed to dry. 100 μl SRB (0.057% w/v in 1% aque-
ous acetic acid) solution was added to the dry 96-well
plates in each well and allowed staining to occur at
room temperature for 30 min. The sulforhodamine
(SRB) solution was removed by washing the plate five
times with 1% v/v acetic acid in order to remove un-
bound dye. Washed plates were then dried. 200 μl of
10 mM Tris Base (pH 10.5) was added to each well to
solubilize the bound SRB. It was then shaken for 5-
10 min on a shaker platform. Lastly, the plates were
read in a 96-well plate reader with working wavelength
of 570 nm. The O.D of SRB in each well is directly pro-
portional to the cell number so the O.D values can be
plotted against concentration and the IC50 determined.
The viability and growth in the presence of test mater-
ial is calculated by following formula:




HPLC estimation of Luteolin
Samples for HPLC were prepared from the leaves of A.
carnosus extract. 10 mg of ethanolic and aqueous extract
were weighed and separately dissolved in HPLC grade
methanol. They were filtered through a 0.2 μm syringe
filter and transferred to 2 ml eppendorf tubes. The volume
was made up to 2 ml with methanol to obtain 5 mg/ml
concentration. These solutions were further used for
HPLC estimation as test samples. Reference standard
luteolin was prepared by weighing 0.1 mg/ml of luteolin
and dissolving in 1 ml of HPLC grade methanol.
HPLC analysis was performed using Chen X et al
method with slight modification [22]. SCL – 10A VP
HPLC system (Shimadzu, Japan). Reverse phase separation
was performed at room temperature 25°C using C-18
HYPERSIL column (250 × 4.6 mm), particle size 5 mm.
The mobile phase consisted of 60% water i.e. (water con-
taining 0.5% H3PO4 and methanol) (solvent A) and 40%Acetonitrile (solvent B). The flow rate was kept at 1 ml/
min and the injection volume was 20 μl. The chromato-
gram peaks were detected at 254 nm. Detector used was
SCL – 10A VP, UV-Visible (Shimadzu, Japan). The com-
pounds were identified by comparing the retention times
and peak areas of extracts with that of the reference stand-
ard luteolin.
Statistical analysis
Graphs were prepared in Microsoft office 2010 beta –
Excel. IC50 value was calculated using the linear re-
gression equation in GraphPad Prism 5.0. Data was
represented as mean ± standard error of mean of three
samples. Statistical significance (p) was calculated by
one-way ANOVA followed by Tukey’s post hoc test of
significance where, p <0.05 was considered to be
significant. Statistical comparison between the mean %
viability of each extract and its negative control was done
using one-way ANOVA followed by Dunnett’s post hoc
test of significance wherein p <0.05 and p <0.01 were con-
sidered to be statistically significant and very statistically
significant compared to negative control.
Result
In vitro MTT assay
The ethanolic, aqueous and petroleum ether extracts of
A.carnosus were evaluated for cytotoxicity against breast
adenocarcinoma cell line BT-549 using MTT (3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium brom-
ide) assay. The cytotoxicity results clearly establish that
the petroleum ether and ethanolic extract of A.carnosus
exhibits potent cytotoxic effect against BT-549 with an
IC50 of 18.35 μg/ml and 58.6 μg/ml. Further, both ex-
tracts showed dose-dependent inhibition of cell growth.
The aqueous extract, conversely showed comparatively
less pronounced cytotoxic effect with an IC50 of
238.9 μg/ml (Table 1 and Figure 1). Tukey’s post hoc
tests indicated comparable cytotoxic activity between
petroleum ether extract and paclitaxel as indicated in
Table 1. Dunnett’s post hoc test displayed significant
difference between the mean % viability of different
concentrations of A.carnosus extracts and their corre-
sponding negative control (DMSO).
In vitro SRB assay
The ethanolic, aqueous and petroleum ether extracts of A.
carnosus were evaluated for cytotoxicity against breast
adenocarcinoma cell line BT-549 using SRB ( Sulforhoda-
mine B) assay (Table 2 and Figure 2). Like MTT assay, re-
sults of SRB distinctly prove that petroleum ether extract
and ethanolic extract of Anisochilus carnosus showed po-
tent dose- dependent cytotoxic effect against BT-549 with
an IC50 of 22.5 μg/ml and 87.24 μg/ml respectively. The
aqueous extract, however showed less cytotoxic effect with




Aqueous extract Ethanolic extract Pet. ether extract Paclitaxel
0 100 ± 5.875 100 ± 5.875 100 ± 5.875 100 ± 2.09
6.25 - - - 80.32 ± 0.366**
12.5 - - - 42.56 ± 1.863**
25 94.04 ± 1.729 75.26 ± 2.654* 44.92 ± 2.631** 22.83 ± 1.22**
50 80.87 ± 2.462* 54.14 ± 4.610** 30.23 ± 3.662** 10.66 ± 0.46**
100 71.12 ± 1.950** 26.66 ± 2.951** 12.73 ± 4.242** -
200 58.79 ± 2.278** 12.06 ± 1.104** 8.16 ± 1.063** -
IC 50 value 238.91 58.64
a 18.35a, b 11.34b
Results were expressed as Mean ± SEM (n = 3) and analysed using one-way ANOVA followed by Tukey’s post hoc test of significance [where different alphabets
denote significant difference (p <0.05)]. Statistical comparison between the mean % viability of each extract and its negative control was performed using
one-way ANOVA followed by Dunnett’s post hoc test of significance wherein *p <0.05 and **p <0.01 were considered to be statistically significant and very
statistically significant compared to negative control. A.carnosus extracts were tested at concentrations of 200, 100, 50, 25 μg/ml (they were not tested at
concentrations of 6.25 and 12.5 μg/ml). Paclitaxel was tested at concentrations of 6.25, 12.5, 25 and 50 μg/ml.
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comparable cytotoxic activity between petroleum ether
extract and paclitaxel. Dunnett’s post hoc test showed
significant difference between the mean % viability of dif-
ferent concentrations of A.carnosus extracts and their cor-
responding negative control (DMSO).
Overall, cytotoxicity of A.carnosus extracts against BT-
549 cell line followed a similar trend by both MTT and
SRB assay.HPLC estimation of Luteolin
The estimation of luteolin content in various extracts
(ethanolic and aqueous) with luteolin as the marker com-
pound was performed using HPLC (High performance
Liquid Chromatography). Luteolin eluted at RT 4.542 in
both ethanolic and aqueous extract (as can be seen inFigure 1 In vitro MTT assay on BT-549 cells. BT-549 cells were incubated
ethanolic and petroleum ether extracts of Anisochilus carnosus. Growth inh
survival was calculated by defining the absorption of cells without Anisochichromatograms in Figure 3A-C). The results shown in
Table 3 and Figure 3(A-C) indicate that the ethanol
extract of A. carnosus contains the highest concentration
of luteolin (0.372% w/w). The aqueous extract contained
lower concentration of luteolin (0.282% w/w).
The cytotoxic activity of ethanolic extract is probably
due to the presence of luteolin. The presence of luteolin
in ethanolic extract is evidently demonstrated through
HPLC fingerprinting (Figure 3).Discussion
Phytocompounds have been an excellent source of drug
leads since several decades. They are unique in that they
present an eclectic range of structural diversity and are by
nature “biologically friendly” [23]. A recent survey of the
European anticancer drug market revealed that of the 155with different concentrations (25, 50, 100, 100 μg/ml) of aqueous,
ibition was determined by the MTT assay. The percentage of cell
lus carnosus treatment as 100%.




Aqueous extract Ethanolic extract Pet. ether extract Paclitaxel
0 100 ± 6.198 100 ± 6.198 100 ± 6.198 100 ± 2.44
6.25 - - - 86.25 ± 0.441**
12.5 - - - 45.36 ± 0.582**
25 89.50 ± 0.883 80.57 ± 1.972* 46.68 ± 5.838** 29.51 ± 1.54**
50 71.01 ± 2.141** 59.04 ± 3.507** 36.89 ± 3.525** 16.46 ± 2.313**
100 61.44 ± 1.129** 36.38 ± 1.396** 18.73 ± 2.505** -
200 52.43 ± 0.745** 11.85 ± 2.371** 10.84 ± 2.741** -
IC 50 value 211.26 87.24 22.5
a 13.91a
Results were expressed as Mean ± SEM (n = 3) and analysed using one-way ANOVA followed by Tukey’s post hoc test of significance [where different alphabets a,
b denote significant difference (p <0.05)]. Statistical comparison between the mean % viability of each extract and its negative control was performed using one-
way ANOVA followed by Dunnett’s post hoc test of significance wherein *p <0.05 and **p <0.01 were considered to be statistically significant and very statistically
significant compared to negative control. A.carnosus extracts were not tested at concentrations of 200, 100, 50, 25 μg/ml (they were not tested at concentrations
of 6.25 and 12.5 μg/ml). Paclitaxel was tested at concentrations of 6.25, 12.5, 25 and 50 μg/ml.
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pletely of natural origin or derived therefrom [24].
A.carnosus, a plant that grows commonly in high alti-
tude regions has been attributed with innumerable ben-
efits in folk medicine. Recently, a study has indicated
nanoparticles synthesised from A.carnosus extract to
show potent antimicrobial activity against microbes
such as B. subtilis, K. pneumonia, E.coli and P.aerugi-
nosa [25]. Azmathulla et al. [26] investigated the anti-
ulcer property of A.carnosus and it was found to
possess powerful gastric healing properties. Several re-
ports have also shown A.carnosus ethanol extract to be
an effective hepatoprotective agent [27,28]. Furthermore,
A.carnosus leaves showed good analgesic and antipyretic
activity [29]. Such strong pharmacological activity of A.
carnosus could be credited to the innumerable phytocom-
pounds present in them.
In the present study, we have evaluated the cytotoxic
potential of A.carnosus extracts using MTT and SRB assay.Figure 2 In vitro SRB assay on BT-549 cells. BT-549 cells were incubated
ethanolic and petroleum ether extracts of Anisochilus carnosus. Growth inh
survival was calculated by defining the absorption of cells without AnisochiMTT assay establishes the cell viability on the basis of re-
duction of yellow tetrazolium MTT to purple formazan dye
by mitochondrial dehydrogenase enzyme, an enzyme exclu-
sively present in viable cells. As such, the quantity of forma-
zan reveals the number of metabolically active viable cells
[30]. The petroleum ether and ethanolic extract of A.carno-
sus showed potent cytotoxic potential against BT-549 with
an IC50 of 18.35 μg/ml and 58.6 μg/ml respectively. Further,
both extracts showed dose-dependent inhibition of tumor
cell growth. The aqueous extract also displayed dose
dependent cytotoxicity against BT-549 cell line with an
IC50 of 238.9 μg/ml (Table 1 and Figure 1). According to
the United States NCI plant screening program, a plant
extract is usually considered to have active cytotoxic effect,
if its IC50 value is 30 μg/ml or less [31]. Skehan and his co-
workers conceived a novel method called Sulforhodamine
B (SRB) assay to determine the cytotoxicity and cell prolif-
eration based on the measurement of cellular protein con-
tent [32]. The petroleum ether and ethanolic extract of A.with different concentrations (25, 50, 100, 100 μg/ml) of aqueous,
ibition was determined by the SRB assay. The percentage of cell
lus carnosus treatment as 100%.
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Figure 3 Estimation of Luteolin in A.carnosus extracts. Representative chromatograms illustrate High Performance Liquid Chromatography
(HPLC) of luteolin (A), ethanolic extract (B) and aqueous extract (C). Absorbance was measured at 254 nm. Luteolin eluted at RT 4.5. The arrow
marks indicate the location of luteolin peak.
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assay with an IC50 of 22.5 μg/ml and 87.24 μg/ml respect-
ively. Additionally, both extracts exhibited dose-dependent
inhibition of cell growth. The aqueous extract also dem-
onstrated dose dependent cytotoxicity with an IC50 of
211.26 μg/ml (Table 2 and Figure 2). The mean % via-
bility of all three extracts of A.carnous at concentra-
tions of 50, 100 and 200 μg/ml was observed to beTable 3 Estimation of Luteolin by HPLC
S. no Sample Retention time Peak area Concentration
(% w/w)
1 Luteolin 4.550 8385954 100
2 Ethanolic extract 4.542 1557755 0.372
3 Aqueous extract 4.542 1183180 0.282significantly different from their corresponding negative
control (0.01% DMSO) by both cytotoxicity assays.
It was noted that IC50 values attained through MTT and
SRB assay were highly comparable. A.carnosus aqueous
extract gave a slightly higher IC50 value by MTT assay.
IC50 values of ethanolic and petroleum ether extracts, on
the other hand were found to be comparable though
somewhat higher by SRB assay. Overall, there was good
correlation between IC50 values obtained by both cytotox-
icity assays, thereby confirming that A.carnosus extracts
possess potent cytotoxicity.
We observed that aqueous extract of A.carnosus dis-
played comparatively less cytotoxic activity against BT-549
cell line than petroleum ether and ethanolic extract.
Typically, a plant’s aqueous extract exerts cytotoxicity
at comparatively higher concentration (approximately
250 μg/ml) than extracts obtained from other solvents
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probably because water extracts in general, are thought
to comprise of highly polar constituents such as carbo-
hydrates, glycosides, proteins and minerals [34]. More-
over, phytochemical screening of A.carnosus successive
water extract revealed the presence of constituents such
as carbohydrates, glycosides, saponins and tannins in
the water extract [18]. Specifically, phytosterols were
absent in A.carnosus aqueous extract. As a general rule,
phytosterols are insoluble in water, but soluble in non-
polar solvents (like hexane, iso-octane and 2-propanol)
[35]. Hence, the possibility of phytosterols being
extracted into water is very less. Numerous studies have
credited phytosterols with potent cytotoxic activity
[36]. We presume the absence of phytosterols and ter-
penoids in aqueous extract could be a probable reason
for low cytotoxic activity of water extract.
Reactive oxygen species (ROS), generated as a result
of oxidative stress has been implicated in the develop-
ment of cancer. ROS are capable of initiating signal-
transduction pathways and inducing the transcription
of proto-oncogenes such as c-fos, c-jun, c-myc, all of
which are involved in accelerating the tumor growth
[37]. Antioxidants, well-known for their high ROS scav-
enging potential are able to protect the cells from ROS
attack and may thereby play a crucial role in the pre-
vention of cancer [38]. The ROS scavenging potential
of A.carnosus was investigated by Lobo R et al [39] and
it was observed that the methanolic and aqueous ex-
tracts of A.carnosus exhibited potent antioxidant activ-
ity. We believe the high ROS scavenging potential of A.
carnosus extracts could be a probable cause for its
potent cytotoxic effect.
Several studies have indicated phytosterols to have
tremendous antitumor potential. Being the counterparts
of cholesterol in plants, they resemble cholesterol struc-
turally, except for the C24 position on the sterol side chain
[36,40]. The anticancer effects of β-sitosterol, a dietary
phytosterol have been documented in colon [41], breast
[42] and prostate cancer [43]. In fact, 16 μmol/L β-
sitosterol was able to induce cell death in MDA-MB-231
breast cancer cell line and LNCaP prostate cancer cell line
four to six fold higher than control levels after 3-5 days of
treatment [36]. In 1980, Raicht et al. [44] also reported
that dietary β-sitosterol can provide protection from
chemically induced colon cancer. They studied the devel-
opment of methylnitrosourea induced tumor in rats fed
with 0.2% β-sitosterol in their diet for 28 weeks. A remark-
able decline was observed both in the number of rats that
developed the tumor and the number of tumors per rat
with β-sitosterol feeding. Besides, dietary supplementation
of β-sitosterol at 60 mg/day for 6 months helped to
improve the clinical symptoms of prostatic hyperplasia in
humans [45], a disorder characterized by polyuria due tothe enlargement of the prostate gland. For the same rea-
son, epidemiologic studies propose a link between lower
levels of prostatic cancer in Asians and vegetarians with
diets rich in phytosterols compared with the Western diet
[46]. Phytochemical screening of A.carnosus indicated the
presence of phytosterols in the petroleum ether successive
extract [18]. Consequently, the high cytotoxic activity of
the petroleum ether extract reported in this study could
be credited to the phytosterols present in A.carnosus
petroleum ether extract.
Flavonoids are another group of nutritional phyto-
chemical that has been widely acknowledged for its re-
markable cancer-protective effects. Luteolin, a naturally
occurring flavonoid exhibits powerful antitumor poten-
tial. Samy et al. [47] evaluated the anti-tumour potential
of luteolin and cyclophosphamide combination against
DMBA induced mammary carcinogenesis in Wistar rats
and it was observed that the combination treatment
reduced the incidence of tumour and decreased the
tumour volume. Also, in a DMH induced colon cancer
model, luteolin administration decreased the occurrence
of colon cancer, total number and mass of tumors per
rat by almost 90% in a dose-dependent manner both in
initiation and post-initiation stages of colon carcinogen-
esis [48]. Luteolin isolated from Terminalia arjuna was
found to inhibit proliferation of MCF-7breast cancer
and HepG2 liver cancer cells in a dose dependent man-
ner [49]. Luteolin also stalled proliferation of various
tumour cell lines in vitro such as epidermoid, pancreatic,
hepatoma, esophageal and lung cancer cell lines [50].
Hence, the potent cytotoxic activity of ethanolic extract
of A.carnosus reported in this study can be attributed to
its luteolin content. This is the first report on cytotox-
icity of different extracts of A.carnosus against BT-549
breast adenocarcinoma cell line.
Conclusion
The petroleum ether and ethanolic extracts showed re-
markable cytotoxic activity against BT-549, an estrogen
independent breast carcinoma cell line. It can thus be
concluded that these extracts have the potential to be
developed as a chemopreventive option for cancer. How-
ever, it is very difficult to conclude the possible mechan-
ism for their cytotoxic activity at this stage. Hence, further
research in this direction can be attempted to elucidate
the molecular mechanism. Besides, they can be screened
against other cancer cell lines for cytotoxic activity.
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